Targeting VPS4 elicits STING-driven anti-tumor immunity to suppress rhabdomyosarcoma growth.

Oncogene · 2026 · PMC13246437 · PMID 42032367

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Monocyte and macrophage infiltration also trended higher in the DN-VPS4A tumors compared to the GFP tumors, although the increase did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.